Newsletter - Banner

Breadcrumb

Asset Publisher

Webinar: Open Science in Action. “Open for science? See how patients are inspiring our research”

An Open Science webinar with a physician and a patient who will discuss the scientific, personal, technical and ethical challenges of an open access biobank that could potentially save lives.

Ovarian and endometrial cancers: $ 6M closer to a lifesaving screening pap test

Dr. Lucy Gilbert’s research team receives funding to finalize development of the DOvEEgene test

Call for Applications: Executive Director and Chief Scientific Officer, Research Institute of the McGill University Health Centre (RI-MUHC)

The RI-MUHC is seeking a dynamic and strategic leader to serve as its next Executive Director and Chief Scientific Officer (ED/CSO)

Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines

Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers

Reflecting on my Master’s in Experimental Medicine experience

Dermatology resident Abdulhadi Jfri shares his thoughts on undertaking a simultaneous Master’s degree

COVID-19 pandemic: Looking back to better tackle future challenges

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

Made-in-Canada COVID-19 test developed at McGill receives government support

Government support for McGill and RI-MUHC team in COVID-19 testing

Canadian researchers work together to develop made-in-Canada COVID-19 testing capacity

The road towards Canadian testing capacity began in Montreal

ResearchMatch brings researchers together

Sixteen new matches made, eight project funded: life sciences researchers meet data scientists

Webinar: Immunity in our community - how to stay safe in the age of COVID (June 17, 2020)

Immunity in our community - how to stay safe in the age of COVID. Since the onset of the COVID-19 pandemic, the main theme at the forefront of everyone’s mind has been safety.

Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper

A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis

McGill Stem Cell and Regenerative Medicine Network 2017 Symposium (November 13, 2017)

The Third McGill Stem Cell and Regenerative Medicine Network Symposium will be held on November 13 at the Research Institute...

19th Annual International Meakins-Christie Laboratories Workshop: Systems Biology Approaches to Pulmonary Host-Pathogen Interactions (October 30, 2017)

The purpose of this workshop is to highlight the use of experimental designs aimed at deciphering complex networks regulating...

The Government of Quebec Grants $500,000 to McGill University and RI-MUHC to Support Two Collaborative Projects

The Government of Québec has awarded a total of $500,000 in funding to the McGill University and the Research Institute of the McGill...

2019 Black Box Neuroscience and Arts Talk – Biomusic (January 11, 2019)

At the Research Institute of the McGill University Health Centre (RI-MUHC) Glen Site, Drs Sylvia & Richard Cruess Amphitheatre, ES1.1129...

From Patient to Pipette: Unlocking the Insights of Rare Diseases

No diseases are irrelevant, clinician-scientist Donald Vinh explains

2019 Cancer Frontier Lecture (April 16, 2019)

Ras Proteins and their Regulators in Human Disease
Speaker: Frank McCormick, PhD, FRS, DSc (Hon)

Research trainee Jenna Wong uses big data to answer big questions about health

Few doctoral students get to see one of their research papers covered by dozens of media outlets. However, when epidemiology student...

RI-MUHC researchers review diagnostic tests for COVID-19

Study published in the Annals of Internal Medicine